These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 17893202
1. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. Decalf J, Fernandes S, Longman R, Ahloulay M, Audat F, Lefrerre F, Rice CM, Pol S, Albert ML. J Exp Med; 2007 Oct 01; 204(10):2423-37. PubMed ID: 17893202 [Abstract] [Full Text] [Related]
2. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. J Med Virol; 2008 Jun 01; 80(6):980-8. PubMed ID: 18428149 [Abstract] [Full Text] [Related]
3. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha. Schroeder JT, Chichester KL, Bieneman AP. J Allergy Clin Immunol; 2008 Feb 01; 121(2):486-91. PubMed ID: 18036648 [Abstract] [Full Text] [Related]
4. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms. Krishnadas DK, Ahn JS, Han J, Kumar R, Agrawal B. Int Immunol; 2010 Jun 01; 22(6):491-502. PubMed ID: 20410260 [Abstract] [Full Text] [Related]
5. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. Goutagny N, Vieux C, Decullier E, Ligeoix B, Epstein A, Trepo C, Couzigou P, Inchauspe G, Bain C. J Infect Dis; 2004 May 01; 189(9):1646-55. PubMed ID: 15116301 [Abstract] [Full Text] [Related]
6. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. Tsubouchi E, Akbar SM, Horiike N, Onji M. J Gastroenterol; 2004 Aug 01; 39(8):754-62. PubMed ID: 15338369 [Abstract] [Full Text] [Related]
7. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P. Eur J Immunol; 2005 Jul 01; 35(7):2184-90. PubMed ID: 15915542 [Abstract] [Full Text] [Related]
8. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Szabo G, Dolganiuc A. Immunobiology; 2005 Jul 01; 210(2-4):237-47. PubMed ID: 16164031 [Abstract] [Full Text] [Related]
9. The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus. Salem ML, El-Demellawy M, El-Azm AR. Cell Immunol; 2010 Jul 01; 262(2):96-104. PubMed ID: 20338549 [Abstract] [Full Text] [Related]
10. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. Piccioli D, Tavarini S, Nuti S, Colombatto P, Brunetto M, Bonino F, Ciccorossi P, Zorat F, Pozzato G, Comar C, Abrignani S, Wack A. J Hepatol; 2005 Jan 01; 42(1):61-7. PubMed ID: 15629508 [Abstract] [Full Text] [Related]
11. [The role of dendritic cells in the infection by HIV and HCV]. Belmonte L, Parodi C, Bare P, Baston M, Bracco MM, Ruibal-Ares B. Medicina (B Aires); 2007 Jan 01; 67(1):63-70. PubMed ID: 17408026 [Abstract] [Full Text] [Related]
12. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, Szczeponek A, Gerken G, Schlaak JF. J Hepatol; 2008 Jun 01; 48(6):914-22. PubMed ID: 18362039 [Abstract] [Full Text] [Related]
13. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Ulsenheimer A, Gerlach JT, Jung MC, Gruener N, Wächtler M, Backmund M, Santantonio T, Schraut W, Heeg MH, Schirren CA, Zachoval R, Pape GR, Diepolder HM. Hepatology; 2005 Mar 01; 41(3):643-51. PubMed ID: 15726647 [Abstract] [Full Text] [Related]
14. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Wu P, Wu J, Liu S, Han X, Lu J, Shi Y, Wang J, Lu L, Cao X. Clin Immunol; 2008 Oct 01; 129(1):40-8. PubMed ID: 18684674 [Abstract] [Full Text] [Related]
15. Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C. Albert ML, Decalf J, Pol S. J Hepatol; 2008 Dec 01; 49(6):1069-78. PubMed ID: 18929418 [Abstract] [Full Text] [Related]
17. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response. Bode JG, Brenndörfer ED, Häussinger D. Biol Chem; 2008 Oct 01; 389(10):1283-98. PubMed ID: 18713016 [Abstract] [Full Text] [Related]
18. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity. Cederarv M, Söderberg-Nauclér C, Odeberg J. Immunobiology; 2009 Oct 01; 214(5):331-41. PubMed ID: 19152985 [Abstract] [Full Text] [Related]
19. NK cells at the interface between innate and adaptive immunity. Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L. Cell Death Differ; 2008 Feb 01; 15(2):226-33. PubMed ID: 17541426 [Abstract] [Full Text] [Related]
20. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G. J Immunol; 2006 Nov 15; 177(10):6758-68. PubMed ID: 17082589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]